Hi Traders
We can't say much here!
As always history has shown us when a new drug goes on the market we have 3 scenarios:
1 we're going up (green path)
2 the medicine is not good we are going down (red path)
3 we don't know what the medicine is like until many people take it let's go sideways (purple path)
with all that is happening at the moment we are...
Banks has a lot of Long Hedges Open on these tickers, they have been overall short the last 1,5 years.
Now in March they began to close their first Long Hedge position.
Question right now is, did they build up big position yet for the longside, or they just sold their long Hedge and want price to go down further.
If we hold the lows of 0,59 here - no weekly close...
I decided to start this new format to take advantage of short opportunities that arise when a week stock has gone parabolic.
I have some criteria to sift through opportunities and choose the best:
1) The company is relatively unknown (normally belongs to the OTC market) and financially weak (medical companies normally satisfy these criteria)
2) The company has...
Short squeeze stocks have become a favorite recently. KALA has started getting wrapped into the conversation. Looking at details from sites like FinViz, short float is around 20% meanwhile the float itself shows to be around 42 million shares. Plotting some levels, you'll notice that KALA is still in the lower channel on the fib retracement slowly heading toward...
Kala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye Disease
-- FDA Sets PDUFA Goal Date of October 30, 202
The idea is to go long hoping to get the good news from the FDA.
